In:
European Psychiatry, Cambridge University Press (CUP), Vol. 19, No. 4 ( 2004), p. 233-234
Kurzfassung:
A 25-year-old man with DSM-IV-TR Axis I social phobia and Axis II avoidant personality disorder and erectile dysfunction, presenting with depression, anxiety and insomnia, responded partially to extended release oral venlafaxine (75 mg/die for 6 weeks), but developed side effects and worsening symptoms when dose was increased to 150 mg/die; he responded to a combination of 75 mg/die venlafaxine and 4 mg/die reboxetine and improved on most of his symptoms.
Materialart:
Online-Ressource
ISSN:
0924-9338
,
1778-3585
DOI:
10.1016/j.eurpsy.2003.07.015
Sprache:
Englisch
Verlag:
Cambridge University Press (CUP)
Publikationsdatum:
2004
ZDB Id:
2005377-0
